Thank you, readers! That's all from CNBCTV18.com's live market coverage on July 14, 2022. Stay tuned for other updates on our website: CNBCTV18.com.
Download our mobile app for Android and iOS platforms
Auto sector interesting: HDFC AMC's Roshi Jain
Roshi Jain, Senior Equity Fund Manager at HDFC AMC, tells CNBC-TV18 that in her view, the threat of disruption from EVs is real. "I would not necessarily focus on very near term demand or commodity price impacts, but would say that companies balancing the transition well without risking their balance sheets will do well," she says.
"Demand drivers are in place in India... It is a company-specific call and those that can manage this transition probably will be beneficiaries," Jain adds.
Prefer midcaps in the IT pack: SBI Securities' Sunny Agrawal
Sunny Agrawal of SBI Securities tells CNBC-TV18 that he prefers midcap stocks within the IT basket. "The overall IT pack has corrected significantly over the last 6-9 months, whether it is largecaps or midcaps. Growth in the long-term remain at above a 15-20 percent CAGR in the midcap IT space as against 10-12 percent in the largecap IT pack," he says.
He suggests buying the dip in midcap IT from a long-term perspective to expect a return of 15-20 percent over the next 12 months.
Sell SBI Futures, buy Dr Reddy's Laboratories: Jay Thakkar
Here are two recommendations by Jay Thakkar of Marwadi Shares and Finance
-- Sell SBI Futures for a target of Rs 469-460 with a stop loss at Rs 489
-- Buy Dr Reddy’s Laboratories (DRL) for a target of Rs 4,700 and Rs 4,760 with a stop loss at Rs 4,470